Developer docs
API playgroundTry for free, no card

Search company profiles

Surgipharm

Full company profile

uuid000t43u

Namestring
Surgipharm
Legal namestring
Surgipharm Uganda Limited
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Surgipharm Uganda Limited is a privately held pharmaceutical and medical supplies distributor founded in 1997 and headquartered in the Ntinda Industrial Area of Kampala, Uganda. The company imports, exports, distributes and markets a diversified health product portfolio organised across eight segments: branded pharmaceuticals, generic pharmaceuticals, OTC pharmaceuticals, FMCG, surgical procedures, diagnostics and medical systems, hospital consumables, and veterinary products. Its portfolio comprises over 600 items sourced from more than 40 international manufacturers including GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Becton Dickinson, Smith & Nephew and Medtronic, distributed across Uganda and Rwanda from cold chain storage facilities in Kampala.

The operating model is B2B enterprise field sales, with dedicated Medical Representative teams selling into government health facilities, NGOs, hospitals, research institutions, large wholesalers and retailers through a tender-based procurement process that the company treats as a core activity. Revenue is generated through product distribution (transactional margins), special procurement services for institutional clients, and value-add services including medical training, health consulting, equipment installation and maintenance, technical consulting and after-sales support, plus 24-hour emergency supply availability. ISO 9001 certification via IQNet supports tender prequalification and quality assurance.

Strategically, Surgipharm is integrated into several donor-funded and government public health programs in Uganda, including the ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch Government, the Affordable Medicines Facility - Malaria (AMFM) as a first-line buyer for the Global Fund, and the Consortium For ACT Private Sector Subsidy (CAPSS) with Medicines for Malaria Venture and the Ugandan Ministry of Health. The company is a privately held Ugandan private limited company with no disclosed parent, investors, funding rounds, revenue figures, or public management roster; ownership and shareholder structure constitute a material data gap.

Short descriptiontext

Surgipharm Uganda Limited is a Kampala-headquartered pharmaceutical and medical supplies distributor founded in 1997, importing and distributing 600+ products from 40+ international manufacturers to hospitals, government health organisations, NGOs, wholesalers and retailers across Uganda and Rwanda.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKampala, Uganda
HQ citystring
Kampala
HQ countrystring
Uganda
HQ regionstring
Africa
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, medical supplies, healthcare logistics, diagnostic equipment, cold chain storage
Industry6 codes
1Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
CodeHLAIAJAFPrimaryYes
2Medical Supplies & Consumables Wholesale (Non-Device)
CodeCRAOAHAEPrimaryNo
3Health Supply Chain, Procurement & Access to Medicines
CodeBPADAIAIPrimaryNo
4Vaccines & Public Health Product Distribution
CodeCRAOAHAIPrimaryNo
5OTC Medicines & Consumer Health Products Distribution
CodeCRAOAHABPrimaryNo
6Pet Health & Wellness Distribution (Supplements, OTC, Preventives)
CodeCRAOAKACPrimaryNo
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code4 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Surgical & Medical Instruments & Apparatus3841
  • Biological Products, (No Disgnostic Substances)2836
Product category
Pharmaceutical Distribution
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Distribution
TypeTransaction Fee
Description

Importation, exportation, distribution and marketing of pharmaceutical products including branded pharmaceuticals, generic pharmaceuticals, OTC products, FMCG, surgical products, diagnostics equipment, hospital consumables, and veterinary products. Revenue generated from product sales through distribution network covering Uganda and Rwanda.

surgipharm.co.ug
2Professional Services
TypeProfessional Services
Description

Medical training programmes, health consulting services, equipment installation and maintenance, technical consulting, and after-sales support services offered to customers.

surgipharm.co.ug
3Special Procurement Services
TypeManaged Services
Description

Tender-focused procurement services for institutional customers, including development and review of procurement plans, documentation preparation, and supply of broad range of products at competitive prices.

surgipharm.co.ug
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing for institutional and retail customers
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available; inquiries and quotations handled through online forms and direct contact with sales team.

surgipharm.co.ug
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Surgipharm imports, exports, distributes, and markets pharmaceutical products, medical devices, diagnostics, surgical supplies, hospital consumables, OTC medicines, FMCG health products, and veterinary medicines across Uganda and Rwanda. The portfolio covers more than 600 items sourced from 40+ international manufacturers, supported by cold-chain storage, equipment installation and maintenance, training, consulting, and special procurement services for institutional customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 600 product items available
+2 more records
Product overview1 text field

Surgipharm Uganda Limited operates as a pharmaceutical and diagnostics supply company with a diversified portfolio spanning eight business segments: Branded Pharmaceuticals (from GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Adcock Ingram, Besins, Merck, Organon), Generic Pharmaceuticals, OTC Pharmaceuticals, Fast Moving Consumer Goods, Surgical Procedures (including Smith & Nephew orthopaedic products), Diagnostics & Medical Systems (Hemocue, NIHON KOHDEN, BECKMAN COULTER), Hospital Consumables, and Veterinary Products. Their product portfolio consists of over 600 items from over 40 international pharmaceutical and medical supply companies. Complementing their product offerings, they provide related services including Medical Training, Health Consulting, Equipment Installation & Maintenance, Special Procurement Services, Technical Consulting, and After Sales Support. The company distributes throughout Uganda and Rwanda.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint venture partner in ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch government. The partnership aims to improve access to quality healthcare services in Uganda through provision of buffer stock of antiretroviral (ARV) drugs supplied to organisations at not-for-profit prices.

Strategic tierCoreTypeOthers
Description

Funding and support partner in ARV Access For Africa (AA4A) initiative to improve access to antiretroviral drugs in Uganda through not-for-profit pricing.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swiss not-for-profit public-private partnership participant in Consortium For ACT Private Sector Subsidy (CAPSS) with Ugandan Ministry of Health to provide highly subsidised and repackaged artemisinin-based combination therapies (ACTs) through private sector in four districts in eastern Uganda.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Host and manager of Affordable Medicines Facility - Malaria (AMFM), an innovative financing mechanism designed to expand access to the most effective malaria treatment (ACTs). Surgipharm is a first line buyer for Uganda working with manufacturers to avail subsidised ACTs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government partner in multiple initiatives including National Injection Safety Campaign, Consortium For ACT Private Sector Subsidy (CAPSS), and various health programmes. Represents the company in national health policy implementation.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership in National Injection Safety Campaign working to reduce transmission of communicable diseases through stocking and availing innovative syringes and sharps collector products through policy implementation and sensitising programmes.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership for orthopaedic and spinal procedures focusing on introduction and facilitation of modern procedures through hands-on training and investment in requisite implants and instrumentation.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with Smith & Nephew focusing on orthopaedic and spinal procedures including hands-on training and investment in implants and instrumentation resulting in lower end-user costs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers6 records
TypeEmerging player
Description

mPharma is a Ghana-headquartered, venture-backed healthcare company that operates pharmacy retail and pharmaceutical distribution across multiple African countries and is expanding into Uganda and neighboring markets. It overlaps with Surgipharm in pharmaceutical distribution and supplier relationship management for branded and generic medicines in sub-Saharan Africa.

TypeBroad incumbent
Description

Cipla is one of India's largest pharmaceutical manufacturers with established distribution operations across Africa, including branded ARVs and generics in Uganda. It is comparable to Surgipharm as both a supplier principal and an indirect competitor in branded and generic pharmaceutical distribution across East Africa.

3Imperial Health Sciences
TypeDirect peer
Description

Imperial Health Sciences, part of Imperial Group, is the largest pharmaceutical and FMCG wholesaler in East and Southern Africa, operating cold-chain distribution across Kenya, Uganda, Tanzania, and beyond. It directly competes with Surgipharm in pharmaceutical and medical supplies wholesale distribution in Uganda and Rwanda, with a comparable multi-segment portfolio and government/institutional customer base.

TypeDirect peer
Description

Beta Healthcare International is a Kenya-based pharmaceutical manufacturer and distributor with a broad portfolio across branded pharma, OTC, FMCG, and veterinary products across East Africa. It is comparable to Surgipharm as a multi-segment East African pharma player serving both institutional and retail channels.

TypeDirect peer
Description

Medsource is a pharmaceutical and medical supplies wholesaler operating across East Africa, supplying hospitals, pharmacies, and NGOs with branded and generic medicines. It is comparable to Surgipharm in target customer mix (institutional/NGO/government) and product breadth across pharmaceutical and medical consumables in the East African region.

TypeBroad incumbent
Description

Novartis and its Sandoz generics division operate commercial pharmaceutical distribution in East Africa, including branded and generic medicines in Uganda. It is comparable to Surgipharm both as a multinational principal whose products Surgipharm distributes and as a broader pharma player operating in the same regional pharmaceutical market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Surgipharm

Pharmaceutical Distributionsurgipharm.co.ug

Surgipharm Uganda Limited is a Kampala-headquartered pharmaceutical and medical supplies distributor founded in 1997, importing and distributing 600+ products from 40+ international manufacturers to hospitals, government health organisations, NGOs, wholesalers and retailers across Uganda and Rwanda.

What Surgipharm does

Surgipharm Uganda Limited is a privately held pharmaceutical and medical supplies distributor founded in 1997 and headquartered in the Ntinda Industrial Area of Kampala, Uganda. The company imports, exports, distributes and markets a diversified health product portfolio organised across eight segments: branded pharmaceuticals, generic pharmaceuticals, OTC pharmaceuticals, FMCG, surgical procedures, diagnostics and medical systems, hospital consumables, and veterinary products. Its portfolio comprises over 600 items sourced from more than 40 international manufacturers including GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Becton Dickinson, Smith & Nephew and Medtronic, distributed across Uganda and Rwanda from cold chain storage facilities in Kampala.

The operating model is B2B enterprise field sales, with dedicated Medical Representative teams selling into government health facilities, NGOs, hospitals, research institutions, large wholesalers and retailers through a tender-based procurement process that the company treats as a core activity. Revenue is generated through product distribution (transactional margins), special procurement services for institutional clients, and value-add services including medical training, health consulting, equipment installation and maintenance, technical consulting and after-sales support, plus 24-hour emergency supply availability. ISO 9001 certification via IQNet supports tender prequalification and quality assurance.

Strategically, Surgipharm is integrated into several donor-funded and government public health programs in Uganda, including the ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch Government, the Affordable Medicines Facility - Malaria (AMFM) as a first-line buyer for the Global Fund, and the Consortium For ACT Private Sector Subsidy (CAPSS) with Medicines for Malaria Venture and the Ugandan Ministry of Health. The company is a privately held Ugandan private limited company with no disclosed parent, investors, funding rounds, revenue figures, or public management roster; ownership and shareholder structure constitute a material data gap.

Surgipharm firmographics

Firmographics
Name
Surgipharm
Legal name
Surgipharm Uganda Limited
Website
https://surgipharm.co.ug
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
101–250 employees
Short description
Surgipharm Uganda Limited is a Kampala-headquartered pharmaceutical and medical supplies distributor founded in 1997, importing and distributing 600+ products from 40+ international manufacturers to hospitals, government health organisations, NGOs, wholesalers and retailers across Uganda and Rwanda.
Ownership category
akta.pro rank

Surgipharm industry classification

Industry
Product category
Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
akta.pro secondary industries
Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI), Vaccines & Public Health Product Distribution (CRAOAHAI), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Pet Health & Wellness Distribution (Supplements, OTC, Preventives) (CRAOAKAC)

Keywords

  • Pharmaceutical distribution
  • Medical supplies
  • Healthcare logistics
  • Diagnostic equipment
  • Cold chain storage

Where Surgipharm is headquartered

Location

Headquarters

HQ city
Kampala
HQ country
Uganda
HQ region
Africa

Offices2 records

Markets served

Surgipharm business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Distribution: Importation, exportation, distribution and marketing of pharmaceutical products including branded pharmaceuticals, generic pharmaceuticals, OTC products, FMCG, surgical products, diagnostics equipment, hospital consumables, and veterinary products. Revenue generated from product sales through distribution network covering Uganda and Rwanda.
  2. Professional Services: Medical training programmes, health consulting services, equipment installation and maintenance, technical consulting, and after-sales support services offered to customers.
  3. Special Procurement Services: Tender-focused procurement services for institutional customers, including development and review of procurement plans, documentation preparation, and supply of broad range of products at competitive prices.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based pricing for institutional and retail customers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Surgipharm product offering

Product offering

Core offering

Surgipharm imports, exports, distributes, and markets pharmaceutical products, medical devices, diagnostics, surgical supplies, hospital consumables, OTC medicines, FMCG health products, and veterinary medicines across Uganda and Rwanda. The portfolio covers more than 600 items sourced from 40+ international manufacturers, supported by cold-chain storage, equipment installation and maintenance, training, consulting, and special procurement services for institutional customers.

Product overview

Surgipharm Uganda Limited operates as a pharmaceutical and diagnostics supply company with a diversified portfolio spanning eight business segments: Branded Pharmaceuticals (from GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Adcock Ingram, Besins, Merck, Organon), Generic Pharmaceuticals, OTC Pharmaceuticals, Fast Moving Consumer Goods, Surgical Procedures (including Smith & Nephew orthopaedic products), Diagnostics & Medical Systems (Hemocue, NIHON KOHDEN, BECKMAN COULTER), Hospital Consumables, and Veterinary Products. Their product portfolio consists of over 600 items from over 40 international pharmaceutical and medical supply companies. Complementing their product offerings, they provide related services including Medical Training, Health Consulting, Equipment Installation & Maintenance, Special Procurement Services, Technical Consulting, and After Sales Support. The company distributes throughout Uganda and Rwanda.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Over 600 product items available
  • +2 more outcomes

Companies that use Surgipharm

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Surgipharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Surgipharm partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • i+solutionscoreStrategic or Co-development PartnerJoint venture partner in ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch government. The partnership aims to improve access to quality healthcare services in Uganda through provision of buffer stock of antiretroviral (ARV) drugs supplied to organisations at not-for-profit prices.
  • Dutch GovernmentcoreOthersFunding and support partner in ARV Access For Africa (AA4A) initiative to improve access to antiretroviral drugs in Uganda through not-for-profit pricing.
  • Medicines for Malaria Venture (MMV)coreStrategic or Co-development PartnerSwiss not-for-profit public-private partnership participant in Consortium For ACT Private Sector Subsidy (CAPSS) with Ugandan Ministry of Health to provide highly subsidised and repackaged artemisinin-based combination therapies (ACTs) through private sector in four districts in eastern Uganda.
  • Global FundcoreStrategic or Co-development PartnerHost and manager of Affordable Medicines Facility - Malaria (AMFM), an innovative financing mechanism designed to expand access to the most effective malaria treatment (ACTs). Surgipharm is a first line buyer for Uganda working with manufacturers to avail subsidised ACTs.
  • Ugandan Ministry of HealthcoreStrategic or Co-development PartnerGovernment partner in multiple initiatives including National Injection Safety Campaign, Consortium For ACT Private Sector Subsidy (CAPSS), and various health programmes. Represents the company in national health policy implementation.
  • Becton DickinsoncoreChannel Partner/ Reseller/ DistributorPartnership in National Injection Safety Campaign working to reduce transmission of communicable diseases through stocking and availing innovative syringes and sharps collector products through policy implementation and sensitising programmes.
  • Smith & NephewcoreChannel Partner/ Reseller/ DistributorPartnership for orthopaedic and spinal procedures focusing on introduction and facilitation of modern procedures through hands-on training and investment in requisite implants and instrumentation.
  • MedtroniccoreChannel Partner/ Reseller/ DistributorPartnership with Smith & Nephew focusing on orthopaedic and spinal procedures including hands-on training and investment in implants and instrumentation resulting in lower end-user costs.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Surgipharm competitors and assessment

Company assessment

Emerging players

  • mPharma: mPharma is a Ghana-headquartered, venture-backed healthcare company that operates pharmacy retail and pharmaceutical distribution across multiple African countries and is expanding into Uganda and neighboring markets. It overlaps with Surgipharm in pharmaceutical distribution and supplier relationship management for branded and generic medicines in sub-Saharan Africa.

Broad incumbents

  • Cipla: Cipla is one of India's largest pharmaceutical manufacturers with established distribution operations across Africa, including branded ARVs and generics in Uganda. It is comparable to Surgipharm as both a supplier principal and an indirect competitor in branded and generic pharmaceutical distribution across East Africa.
  • Novartis (Sandoz Division): Novartis and its Sandoz generics division operate commercial pharmaceutical distribution in East Africa, including branded and generic medicines in Uganda. It is comparable to Surgipharm both as a multinational principal whose products Surgipharm distributes and as a broader pharma player operating in the same regional pharmaceutical market.

Direct peers

  • Imperial Health Sciences: Imperial Health Sciences, part of Imperial Group, is the largest pharmaceutical and FMCG wholesaler in East and Southern Africa, operating cold-chain distribution across Kenya, Uganda, Tanzania, and beyond. It directly competes with Surgipharm in pharmaceutical and medical supplies wholesale distribution in Uganda and Rwanda, with a comparable multi-segment portfolio and government/institutional customer base.
  • Beta Healthcare International: Beta Healthcare International is a Kenya-based pharmaceutical manufacturer and distributor with a broad portfolio across branded pharma, OTC, FMCG, and veterinary products across East Africa. It is comparable to Surgipharm as a multi-segment East African pharma player serving both institutional and retail channels.
  • Medsource Group: Medsource is a pharmaceutical and medical supplies wholesaler operating across East Africa, supplying hospitals, pharmacies, and NGOs with branded and generic medicines. It is comparable to Surgipharm in target customer mix (institutional/NGO/government) and product breadth across pharmaceutical and medical consumables in the East African region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Surgipharm social profiles

Digital presence

Surgipharm compliance and trust

Trust signal

Compliance1 record

Surgipharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Surgipharm leadership team

Management profile

Number of profiles

Surgipharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Surgipharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgipharm

What does Surgipharm do?

Surgipharm imports, exports, distributes, and markets pharmaceutical products, medical devices, diagnostics, surgical supplies, hospital consumables, OTC medicines, FMCG health products, and veterinary medicines across Uganda and Rwanda. The portfolio covers more than 600 items sourced from 40+ international manufacturers, supported by cold-chain storage, equipment installation and maintenance, training, consulting, and special procurement services for institutional customers.

Is Surgipharm a public or private company?

Surgipharm is a private company. It is classified as unknown and is currently operating.

When was Surgipharm founded?

Surgipharm was founded in 1997. It employs 101 to 250 people.

Where is Surgipharm based?

Surgipharm is headquartered in Kampala, Uganda, in the Africa region.

How does Surgipharm make money?

Three revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are professional Services and special Procurement Services.

Who are Surgipharm's main competitors?

mPharma is listed as an emerging player. Broad incumbents are Cipla and Novartis (Sandoz Division). Direct peers are Imperial Health Sciences, Beta Healthcare International and Medsource Group.

Does Surgipharm have an API?

No public API is recorded for Surgipharm.

What industry is Surgipharm in?

Surgipharm's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 4242 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales